Comparison of the binding specificity of two bacterial metalloproteases, LasB of Pseudomonas aeruginosa and ZapA of Proteus mirabilis, using N-alpha mercaptoamide template-based inhibitor analogues

Biochemical and Biophysical Research Communications
Louise CarsonBrendan F Gilmore

Abstract

The metalloproteases ZapA of Proteus mirabilis and LasB of Pseudomonas aeruginosa are known to be virulence factors their respective opportunistic bacterial pathogens, and are members of the structurally related serralysin and thermolysin families of bacterial metalloproteases respectively. Secreted at the site of infection, these proteases play a key role in the infection process, contributing to tissue destruction and processing of components of the host immune system. Inhibition of these virulence factors may therefore represent an antimicrobial strategy, attenuating the virulence of the infecting pathogen. Previously we have screened a library of N-alpha mercaptoamide dipeptide inhibitors against both ZapA and LasB, with the aim of mapping the S1' binding site of the enzymes, revealing both striking similarities and important differences in their binding preferences. Here we report the design, synthesis, and screening of several inhibitor analogues, based on two parent inhibitors from the original library. The results have allowed for further characterization of the ZapA and LasB active site binding pockets, and have highlighted the possibility for development of broad-spectrum bacterial protease inhibitors, effective again...Continue Reading

References

Jun 1, 1992·The Journal of Veterinary Medical Science·Y TamuraM Nakamura
Dec 1, 1993·Microbiological Reviews·C C Häse, R A Finkelstein
Sep 1, 1995·Journal of Industrial Microbiology·A Boyd, A M Chakrabarty
Jan 1, 1995·Advances in Experimental Medicine and Biology·M A KerrB W Senior
Sep 1, 1996·Journal of Medical Microbiology·C Kooi, P A Sokol
Sep 8, 1998·Microbiology and Molecular Biology Reviews : MMBR·M B RaoV V Deshpande
Mar 7, 2000·Combinatorial Chemistry & High Throughput Screening·J F LynasD A Owen
Feb 15, 1972·FEBS Letters·B Frangione, E C. Franklin
Aug 9, 2003·Microbiology·Brigitte A CowellSuzanne M J Fleiszig
Oct 7, 2004·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Niels Høiby
Nov 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Pascal AuffingerP Shing Ho
Feb 8, 2005·American Journal of Respiratory and Critical Care Medicine·Ruxana T SadikotAlice S Prince
Nov 23, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jeff G LeidAlyssa K Jeffers
Oct 3, 2006·Journal of Molecular Modeling·Peter PolitzerJane S Murray
Sep 29, 2007·Science·Klaus MüllerFrançois Diederich
Sep 24, 2009·Bioorganic & Medicinal Chemistry Letters·George R CathcartBrian Walker
May 26, 2015·Microbes and Environments·Souichiro Kato

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.